Table 2.
Comparison of baseline clinical characteristics of chronic HF patients with and those without anemia
| Anemia (n = 42) | No Anemia (n = 60) | p value | |
|---|---|---|---|
| Age, years | 72 ± 15 | 65 ± 12 | <0.01 |
| Male/female, n | 26/16 | 42/18 | 0.40 |
| BMI | 21.5 ± 5.3 | 22.6 ± 3.6 | 0.13 |
| Etiology, n | |||
| Ischemic | 15 | 19 | 0.08 |
| Valvular | 12 | 7 | |
| Myopathy | 6 | 21 | |
| Hypertensive | 1 | 4 | |
| Arrhythmia | 3 | 6 | |
| Others | 6 | 2 | |
| Comorbidity, % | |||
| Diabetes mellitus | 43 | 35 | 0.53 |
| Hypertension | 50 | 52 | 1.00 |
| Dyslipidemia | 38 | 37 | 1.00 |
| LVEF, % | 42 ± 14 | 34 ± 14 | <0.01 |
| Left ventricular diastolic dimension, mm | 52 ± 10 | 56 ± 10 | 0.05 |
| Left ventricular systolic dimension, mm | 41 ± 11 | 47 ± 12 | <0.01 |
| Left atrial dimension, mm | 45 ± 11 | 43 ± 8 | 0.56 |
| E/E’ | 25.5 ± 13.0 | 22.1 ± 12.0 | 0.18 |
| Hb, g/dl | 10.5 ± 1.0 | 14.0 ± 1.4 | 0.01 |
| Serum creatinine, mg/dl | 1.2 ± 0.5 | 1.0 ± 0.4 | 0.03 |
| eGFR, ml/min/1.73 m2 | 49.5 ± 20.3 | 58.3 ± 19.3 | 0.03 |
| CKD, % | 79 | 62 | 0.05 |
| Albumin, mg/dl | 3.4 ± 0.4 | 3.6 ± 0.5 | 0.56 |
| Brain natriuretic peptide, pg/dl | 846 ± 734.0 | 650 ± 812 | 0.79 |
Values denote means ± SD unless specified otherwise. E/E’ = Ratio of mitral early diastolic peak flow velocity (E) to tissue Doppler early mitral annular diastolic velocity (E').